Literature DB >> 18203004

Vitamin D compounds and myelodysplastic syndrome.

Ryoko Okamoto1, Tadayuki Akagi, Phillip Koeffler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18203004     DOI: 10.1080/10428190701757827

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  5 in total

Review 1.  Differentiation therapy of leukemia: 3 decades of development.

Authors:  Daniel Nowak; Daphne Stewart; H Phillip Koeffler
Journal:  Blood       Date:  2009-02-12       Impact factor: 22.113

2.  Ex vivo drug screening defines novel drug sensitivity patterns for informing personalized therapy in myeloid neoplasms.

Authors:  Michael A Spinner; Alexey Aleshin; Marianne T Santaguida; Steven A Schaffert; James L Zehnder; A Scott Patterson; Christos Gekas; Diane Heiser; Peter L Greenberg
Journal:  Blood Adv       Date:  2020-06-23

Review 3.  Perspectives of differentiation therapies of acute myeloid leukemia: the search for the molecular basis of patients' variable responses to 1,25-dihydroxyvitamin d and vitamin d analogs.

Authors:  Aleksandra Marchwicka; Małgorzata Cebrat; Preetha Sampath; Lukasz Snieżewski; Ewa Marcinkowska
Journal:  Front Oncol       Date:  2014-05-27       Impact factor: 6.244

4.  Regulation of Leukemic Cell Differentiation through the Vitamin D Receptor at the Levels of Intracellular Signal Transduction, Gene Transcription, and Protein Trafficking and Stability.

Authors:  Elżbieta Gocek; Hanna Baurska; Aleksandra Marchwicka; Ewa Marcinkowska
Journal:  Leuk Res Treatment       Date:  2012-05-14

5.  Differentiation therapy of acute myeloid leukemia.

Authors:  Elzbieta Gocek; Ewa Marcinkowska
Journal:  Cancers (Basel)       Date:  2011-05-16       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.